Objective
to report the 10-year clinical outcomes of biodegradable polymer biolimus-eluting stents (BP-BES) compared to durable polymer everolimus-eluting stents (DP-EES)
Study
multicentre, non-inferiority randomised trial
Population
patients with stable and unstable angina
Endpoints
10-year TLR and safety endpoint as composite of death or MI
Conclusion
the cumulative adverse 10-year clinical outcomes were not statistically different of treatment with BP-BES compared to DP-EES
Natsuaki et al. EuroIntervention 2023: 19: 100076